期刊文献+

中药保留灌肠治疗卵巢早衰的临床研究 被引量:16

Clinical Research of Retention Enema with Chinese Medicine in Treatment of Premature Ovarian Failure
下载PDF
导出
摘要 目的观察二仙汤加减中药保留灌肠治疗卵巢早衰对于血清中E2(雌二醇)、FSH(卵泡刺激素)、LH(黄体生成素)的影响。方法设立治疗组及对照组各35例,治疗组采用二仙汤加减中药保留灌肠治疗卵巢早衰,对照组采用二仙汤加减中药汤剂口服治疗卵巢早衰,两组治疗前E2、FSH、LH值差异均无统计学意义(P>0.05)。观察二组治疗前后对于血清中E2、FSH、LH的影响。结果治疗组与对照组中治疗后FSH值与治疗前相比均有显著下降,两组间比较差异有统计学意义(P<0.05)。两组治疗后E2值较治疗前均显著提高,两组间比较差异有统计学意义(P<0.05)。两组治疗后LH值较治疗前均有下降,两组间比较差异无统计学意义(P>0.05)。结论二仙汤加减中药保留灌肠提高血清E2,降低FSH优于单纯中药汤剂口服,同时两组均可以降低LH值。 Objective ToobservetheimpactsofretentionenemawithmodifiedErxiantangonE2, FSHandLHinprematureovarianfailure.Methods Atreatmentandacontrolgroupweresetup,35cases in each one.In the treatment group,the retention enema with modified Erxiantang was used in treatment of premature ovarian failure.In the control group,the oral administration of modified Erxiantang was prescribed. Before treatment,the differences were not significant in E2,FSH and LH between the two groups(P〉0.05). The impacts on serum E2,FSH and LH were observed before and after treatment in the two groups.Results FSHlevelwasreducedsignificantlyaftertreatmentinthetwogroupsascomparedwiththatbeforetreatment. The difference was significant in comparison between the two groups(P〈0.05).After treatment,E2 level was increased significantly as compared with that before treatment in the two groups.The difference was sig-nificant in comparison between the two groups(P〈0.05).After treatment,LH level was reduced in the two groups,and the difference was not significant in comparison between the two groups(P〉0.05).Conclusion TheretentionenemawithmodifiedErxiantangincreasesserumE2andreducesFSH,whichissuperiorto simple oral administration of decoction.All of the two groups reduce LH level.
出处 《世界中西医结合杂志》 2014年第7期729-731,共3页 World Journal of Integrated Traditional and Western Medicine
基金 吉林省中医药管理局中医药科技资助项目(No.2012-059)
关键词 中药保留灌肠 二仙汤 卵巢早衰 Retention Enemawith Chinese Medicine Erxiantang Premature Ovarian Failure
  • 相关文献

参考文献7

二级参考文献24

  • 1[1]Christin-Maitre-S. Premature ovarian insufficiency [ J ]. Rev Prat, 1999,15:1297-1302 被引量:1
  • 2[2]Vegetti W, Marozzi A, Manfredini E, et al. Premature ovarian failure[J]. Mol Cell Endocrinol,2000,161:53-57 被引量:1
  • 3[3]Causio F, Fischetto R, Leonetti T, et al. Ovarian stimulation in a woman with POF and Xo autosome translocation. A case report[J]. J Reprod Med, 2000,45: 235-239 被引量:1
  • 4[4]Doffman DM, C enest DR, Reijo-Pera RA. Human DAZL1 encodes a candidate fertility factor in woman that localizes to the prenatal and postnatal germcells[J]. Hum Reprod, 1999, 14:2531-2536 被引量:1
  • 5[5]Burton KA, Van Ee CC, Purcell K, et al. Autosomal transloca- tion associated with premature ovarian failure [J ]. J Med Genet, 2000,37: 52-55 被引量:1
  • 6[6]Marozzi A,Manfredini E,Tibiletti MG,et al. Molecular defini-tion of Xq common-deleted region in patients affected by POF [J]. Hum Genet, 2000, 107:304-311 被引量:1
  • 7[7]Nawroth F, Schmudt T, Foth D, et al. A woman with climac-teric praecox and X-chromsomal anomaly[J]. Maturitas, 2000,37:129-132 被引量:1
  • 8[8]Murray A, Ennis S, Morton N. No evidance for parent of origin influencing premature ovarian failure in fragile X premutation carriers[J]. Am J Hum Genet,2000,67:153-154 被引量:1
  • 9[9]Hundscheid RD, Sisteramss EA, Thomas CM, et al. Imprinting effect in POF confined to paternally inherited fragile X premu-tation[ J] .Am J Hum Genet,2000,66:413-418 被引量:1
  • 10[10]Guerrero NV,Singh RH,Manatung A,et al. Risk factors for premature ovarian failure in female with galactoseia [ J ]. J Pediatr, 2000,137: 833-841 被引量:1

共引文献341

同被引文献257

引证文献16

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部